Literature DB >> 19750153

Doripenem (doribax), a new carbapenem antibacterial agent.

Olga Hilas, Danielle C Ezzo, Tomasz Z Jodlowski.   

Abstract

Entities:  

Year:  2008        PMID： 19750153      PMCID： PMC2730083     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  7 in total

Review 1.  Doripenem.

Authors:  David Leif Anderson
Journal:  Drugs Today (Barc)       Date:  2006-06       Impact factor: 2.245

2.  Activities of doripenem (S-4661) against drug-resistant clinical pathogens.

Authors:  Ronald N Jones; Holly K Huynh; Douglas J Biedenbach
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 3.  Comparative review of the carbapenems.

Authors:  George G Zhanel; Ryan Wiebe; Leanne Dilay; Kristjan Thomson; Ethan Rubinstein; Daryl J Hoban; Ayman M Noreddin; James A Karlowsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.

Authors:  Jesse L Lunde; Robert E Nelson; Harrison F Storandt
Journal:  Pharmacotherapy       Date:  2007-08       Impact factor: 4.705

Review 5.  Doripenem: S 4661.

Authors: 
Journal:  Drugs R D       Date:  2003

Review 6.  Interaction between valproic acid and carbapenem antibiotics.

Authors:  Hitomi Mori; Kazuhiko Takahashi; Takaharu Mizutani
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

7.  Interaction between valproate and meropenem: a retrospective study.

Authors:  Isabel Spriet; Jo Goyens; Wouter Meersseman; Alexander Wilmer; Ludo Willems; Wim Van Paesschen
Journal:  Ann Pharmacother       Date:  2007-07-03       Impact factor: 3.154
  7 in total
  6 in total

Review 1.  Development of novel antibacterial drugs to combat multiple resistant organisms.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Langenbecks Arch Surg       Date:  2015-02-11       Impact factor: 3.445

Review 2.  Aerosolized antibiotics: do they add to the treatment of pneumonia?

Authors:  Marin H Kollef; Cindy W Hamilton; A Bruce Montgomery
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

Review 3.  A structural, epidemiological & genetic overview of Klebsiella pneumoniae carbapenemases (KPCs).

Authors:  C H Swathi; Rosy Chikala; K S Ratnakar; V Sritharan
Journal:  Indian J Med Res       Date:  2016-07       Impact factor: 2.375

Review 4.  Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Authors:  Viola C Scoffone; Laurent R Chiarelli; Gabriele Trespidi; Massimo Mentasti; Giovanna Riccardi; Silvia Buroni
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

5.  Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland-A Case Study.

Authors:  Ewa Brągoszewska; Izabela Biedroń; Wojciech Hryb
Journal:  Microorganisms       Date:  2020-01-31

Review 6.  New antibiotics for bad bugs: where are we?

Authors:  Matteo Bassetti; Maria Merelli; Chiara Temperoni; Augusta Astilean
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-08-28       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.